Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01662453 · ClinicalTrials.gov registry record
Risk Factors for Sudden Unexplained Death in Epilepsy
A clinical trial of SUDEP, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 800
- Enrollment target
- 1
- Study location
NCT01662453 is a study of SUDEP that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 800 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01662453, a study of SUDEP, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to develop a North American registry for SUDEP cases; requesting family members of epilepsy patients who died suddenly of unclear causes (SUDEP) to contact the study team. The family members who decide to participate in the study will be asked to complete a brief telephone interview about their loved one's epilepsy and seizure history and the circumstances of his or her death. If the death has occurred within the past 24 hours, and the family is willing to consider donating tissue to the study, the subject will be transferred to the Autism Tissue Program, and the remainder of the phone interview will be conducted at a later time. In addition to the phone interview, the family will be asked to provide access to the deceased's medical records. Any costs involved in obtaining medical records will be covered by the study, and all medical information will remain completely confidential.
Conditions Studied
Study Locations (1)
New York
- NYU Comprehensive Epilepsy Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2011-06 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01662453
The ClinicalTrials.gov registry entry for NCT01662453 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with SUDEP appearing as the primary indexed condition, and to 0 interventions.
NCT01662453 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01662453 about?
NCT01662453 is a clinical study titled "Risk Factors for Sudden Unexplained Death in Epilepsy". The main purpose of this study is to develop a North American registry for SUDEP cases; requesting family members of epilepsy patients who died suddenly of unclear causes (SUDEP) to contact the study team. The family members who decide to participate in the study will be asked to complete a brief te...
What is the current status of trial NCT01662453?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2011-06. Estimated completion is 2026-09.
What conditions does trial NCT01662453 study?
This clinical trial studies the following conditions: SUDEP.
Who is sponsoring clinical trial NCT01662453?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01662453 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for SUDEP
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.